标准化护士驱动肠道治疗方案对重症患者肠道频率的影响
Zoe Krenz1, Andrew Bennett1, Katie Hall2
1Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Augusta, Georgia, USA.
在重症监护室 (ICU) 的护士驱动的肠道协议没有改变整体便秘率. 然而,在重症患者中,它显著减少了长期便秘 (超过6天).
科学领域:
- 关键护理医学 关键护理医学
- 胃肠病学 胃肠病学
- 护理研究研究护理研究
背景情况:
- 危急病患者面临高便秘的风险,由于不运动,营养不良和阿片类药物使用.
- 在重症监护室 (ICU) 的便秘会延长住院时间,增加感染风险.
研究的目的:
- 评估护士驱动的肠道协议对ICU患者便秘发病率的有效性.
- 评估该方案对便秘持续时间,停留时间和腹的影响.
主要方法:
- 追溯的前后队列研究,比较ICU患者与没有肠道协议.
- 数据收集于2019年7月至2020年2月 (没有协议) 和2023年7月至2024年2月 (协议) 期间.
- 主要结局:便秘>72小时;次要结局:便秘>6天,ICU/住院时间长,腹.
主要成果:
- 两组之间的便秘>72小时没有显著差异 (79%与78%).
- 肠道协议组的便秘率显著降低>6天 (18%对44%,p=0.043).
- 经过对共变量进行调整 (OR 0.30,p=0.047) 后,这种持续性便秘的减少仍然显著.
结论:
- 护士驱动的肠道协议可能不会改变ICU中的整体便秘率.
- 这些方案可以有效地降低危重病患者长期便秘 (超过6天) 的发生率.
- 可能提供一种策略,以减轻与ICU中长期便秘相关的并发症.
更多相关视频
07:06Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
09:44Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation
Published on: September 11, 2012
相关概念视频
Irritable Bowel Syndrome III: Medical and Nursing Management
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
